Heavy kids may not respond as well to asthma meds

By Kathleen Doheny, HealthDay Reporter
Heavy kids may not respond as well to asthma meds
As weight climbs, so does daily corticosteroid dosage, study says.

(HealthDay) -- Overweight children may not respond as well to common asthma medicines known as inhaled corticosteroids, new research finds.

As a result, they may need more of the long-term control medication, said researcher Dr. Pia Hauk, an assistant professor of at National Jewish Health, in Denver.

"In our patient population, and we see a lot of severe asthmatics, the overweight and have about twice as high an inhaled corticosteroid requirement than those of a healthy weight," Hauk said.

The study was small, including just 61 with , aged 2 to 18, so the results should not be considered conclusive.

Thirty-four children were at healthy , 13 were overweight and 14 obese. Most of the kids, 56, used .

The researchers noted each child's weight and body-mass index (BMI) -- a measurement based on height and weight -- and daily dosage.

They also cultured blood and airway cells, and evaluated the cells' response to asthma medicine, looking at a specific gene that affects the medication response.

Hauk found that as the weight and BMI rose, the decreased. The gene was not expressed as much in overweight children, she said.

The findings were slated for presentation Sunday at the American Academy of Allergy, Asthma & Immunology annual meeting in Orlando, Fla.

About 9 million U.S. children under age 18 have been diagnosed with asthma at some point in their lives, according to the academy. Inhaled corticosteroids, which help reduce airway inflammation and mucus production, have been used for more than 50 years. They include beclomethasone (Qvar), triamcinolone (Azmacort) and mometasone (Asmanex).

About 17 percent of U.S. children and teens are obese, with a BMI over 30, according to the U.S. Centers for Disease Control and Prevention. That's triple the rate of a generation ago. Obese children are more likely to get asthma than normal-weight children.

Hauk speculates that chronic inflammation, which is seen in obesity, may interfere with the body's response to the medicine.

Dr. Sherry Farzan, an allergist and immunologist at North Shore-LIJ Health System, in Great Neck, N.Y., said that other research has shown that overweight adults with asthma had a lower response to their medicines.

"This study is looking more at a cellular level" than some other studies, she said, noting that it lends weight to previous findings.

Hauk said more study is needed before recommending asthma medication changes for . Until more research is in, parents might encourage their child to lose excess weight, she said.

"We know that obesity and being overweight in children is not good in general," Hauk said. "By reducing weight you may decrease inflammation, and you may become more responsive to corticosteroid therapy again."

Data and conclusions presented at medical meetings should be considered preliminary until published in a peer-reviewed medical journal.

More information: To learn more about asthma medication, visit the American Academy of Allergy Asthma & Immunology.

Related Stories

Steroids not as effective in obese asthma patients

Sep 16, 2008

Researchers at National Jewish Health have shown that glucocorticoids, the primary controller medication for asthma, are 40 percent less effective in overweight and obese asthma patients than in those of normal weight. The ...

Obese moms, asthmatic kids

May 19, 2009

Babies born to obese mothers may have an increased risk of asthma, according to data from a new study to be presented on May 19 at the 105th International Conference of the American Thoracic Society in San Diego.

More pounds equals worse asthma?

May 22, 2007

A new study presented at the American Thoracic Society 2007 International Conference finds that obese people are significantly more likely to have persistent or severe persistent asthma than their thinner counterparts.

Recommended for you

Brain neuroinflammation seen in chronic fatigue syndrome

Apr 11, 2014

(HealthDay)—Neuroinflammation markers are elevated in the brains of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) patients compared to healthy controls, according to a study published online ...

Which asthma drugs, dosages work best for African Americans?

Feb 19, 2014

The University of Illinois at Chicago has received funding from the National Institutes of Health to determine what combination and dosages of asthma medications works best to manage asthma in African Americans, who suffer ...

User comments